Podcast: Regulus Therapeutics and microRNA Drug Delivery - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and microRNA Drug Delivery


blog comments powered by Disqus


BioPharm International interviews Bal Bhat, senior director and head of chemistry at Regulus, whose core technology focuses on microRNA drug delivery. Bhat addresses some of the challenges of using microRNA therapeutically and explains Regulus’ conscious decision to use single-stranded microRNA. The possibility of targeting specific tissues using a local delivery system or a packaging molecule is also discussed. Finally, Bhat describes the reactions of potential pharma partners to Regulus’ research data and how the project will move forward.

Related article on Perspectives in MicroRNA Therapeutics

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines

Click here